Cargando…

Molecular Mechanisms of Glutamate Toxicity in Parkinson’s Disease

Parkinson’s disease (PD) is a common neurodegenerative disease, the pathological features of which include the presence of Lewy bodies and the neurodegeneration of dopaminergic neurons in the substantia nigra pars compacta. However, until recently, research on the pathogenesis and treatment of PD ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ji, Wang, Fushun, Mai, Dongmei, Qu, Shaogang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725716/ https://www.ncbi.nlm.nih.gov/pubmed/33324150 http://dx.doi.org/10.3389/fnins.2020.585584

Ejemplares similares

Simvastatin Inhibits Activation of NADPH Oxidase/p38 MAPK Pathway and Enhances Expression of Antioxidant Protein in Parkinson Disease Models
por: Tong, Huichun, et al.
Publicado: (2018)

Glutamic Acid Transporters: Targets for Neuroprotective Therapies in Parkinson’s Disease
por: Li, Xiang, et al.
Publicado: (2021)

Regulation of glutamate transporter trafficking by Nedd4-2 in a Parkinson's disease model
por: Zhang, Yunlong, et al.
Publicado: (2017)

Does Prefrontal Glutamate Index Cognitive Changes in Parkinson’s Disease?
por: Buard, Isabelle, et al.
Publicado: (2022)

A mini-review of the role of vesicular glutamate transporters in Parkinson’s disease
por: Zhao, Cheng, et al.
Publicado: (2023)

Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson's disease
por: Zhang, Yunlong, et al.
Publicado: (2017)

A Computational Model of Loss of Dopaminergic Cells in Parkinson's Disease Due to Glutamate-Induced Excitotoxicity
por: Muddapu, Vignayanandam Ravindernath, et al.
Publicado: (2019)

Changes in GABA and glutamate concentrations during memory tasks in patients with Parkinson’s disease undergoing DBS surgery
por: Buchanan, Robert J., et al.
Publicado: (2014)

New mechanism for glutamate hypothesis in epilepsy
por: Cho, Chang-Hoon
Publicado: (2013)

Prion-Like Mechanisms in Parkinson’s Disease
por: Ma, Jiangnan, et al.
Publicado: (2019)

Molecular Mechanisms Underlying Reciprocal Interactions Between Sleep Disorders and Parkinson’s Disease
por: Yang, Zhengjie, et al.
Publicado: (2021)

The mechanism of exercise for pain management in Parkinson’s disease
por: Yu, Wen-Ye, et al.
Publicado: (2022)

Merkel Cells Release Glutamate Following Mechanical Stimulation: Implication of Glutamate in the Merkel Cell-Neurite Complex
por: Higashikawa, Asuka, et al.
Publicado: (2019)

Molecular Mechanisms Underlying Synaptic and Axon Degeneration in Parkinson’s Disease
por: Gcwensa, Nolwazi Z., et al.
Publicado: (2021)

The Conformationally Sensitive Spatial Distance Between the TM3-4 Loop and Transmembrane Segment 7 in the Glutamate Transporter Revealed by Paired-Cysteine Mutagenesis
por: Qu, Qi, et al.
Publicado: (2021)

Acute Liver Toxicity Modifies Protein Expression of Glutamate Transporters in Liver and Cerebellar Tissue
por: Jiménez-Torres, Catya, et al.
Publicado: (2021)

Characterization of altered molecular mechanisms in Parkinson’s disease through cell type–resolved multiomics analyses
por: Lee, Andrew J., et al.
Publicado: (2023)

Excitatory Dendritic Mitochondrial Calcium Toxicity: Implications for Parkinson’s and Other Neurodegenerative Diseases
por: Verma, Manish, et al.
Publicado: (2018)

A Multi-Scale Computational Model of Levodopa-Induced Toxicity in Parkinson's Disease
por: Muddapu, Vignayanandam Ravindernath-Jayashree, et al.
Publicado: (2022)

Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease
por: Zeng, Xian-Si, et al.
Publicado: (2018)

Proximity of Transmembrane Segments 5 and 8 of the Glutamate Transporter GLT-1 Inferred from Paired Cysteine Mutagenesis
por: Zhang, Xiuping, et al.
Publicado: (2011)

The Accessibility in the External Part of the TM5 of the Glutamate Transporter EAAT1 Is Conformationally Sensitive during the Transport Cycle
por: Zhang, Xiuping, et al.
Publicado: (2012)

Critical amino acids in the TM2 of EAAT2 are essential for membrane‐bound localization, substrate binding, transporter function and anion currents
por: Mai, Dongmei, et al.
Publicado: (2021)

Life without glutamate: the epigenetic effects of glutamate deletion
por: Edelstein, Lawrence, et al.
Publicado: (2014)

Functional investigation of SLC1A2 variants associated with epilepsy
por: Qu, Qi, et al.
Publicado: (2022)

Roles of Glutamate Receptors in Parkinson’s Disease
por: Zhang, Zhu, et al.
Publicado: (2019)

Mechanisms of Body Weight Fluctuations in Parkinson’s Disease
por: Kistner, Andrea, et al.
Publicado: (2014)

Advances of Mechanisms-Related Metabolomics in Parkinson’s Disease
por: Zhang, Yanyan, et al.
Publicado: (2021)

Editorial: Genetic and Epigenetic Mechanisms of Parkinson's Disease
por: Li, Song, et al.
Publicado: (2022)

Update to the Treatment of Parkinson’s Disease Based on the Gut-Brain Axis Mechanism
por: Sun, Xiaohui, et al.
Publicado: (2022)

Molecular Events Underlying Parkinson’s Disease – An Interwoven Tapestry
por: Lim, Kah-Leong, et al.
Publicado: (2013)

Experimentally induced diabetes causes glial activation, glutamate toxicity and cellular damage leading to changes in motor function
por: Nagayach, Aarti, et al.
Publicado: (2014)

Insulin-Like Growth Factor-1 Differentially Modulates Glutamate-Induced Toxicity and Stress in Cells of the Neurogliovascular Unit
por: Hayes, Cellas A., et al.
Publicado: (2021)

Editorial: New paradigm of attention and attention training: Mechanisms and applications
por: Wang, Fushun, et al.
Publicado: (2023)

Non-canonical Mechanisms of Presynaptic Kainate Receptors Controlling Glutamate Release
por: Negrete-Díaz, José V., et al.
Publicado: (2018)

Mechanisms of Invasion in Glioblastoma: Extracellular Matrix, Ca(2+) Signaling, and Glutamate
por: So, Jae-Seon, et al.
Publicado: (2021)

Bioinformatics analysis of potential common pathogenic mechanism for carotid atherosclerosis and Parkinson’s disease
por: Wang, Quan, et al.
Publicado: (2023)

Identification and quantitative assessment of motor complications in Parkinson’s disease using the Parkinson’s KinetiGraph™
por: Qu, Yan, et al.
Publicado: (2023)

Molecular Mechanisms of Short-Term Plasticity: Role of Synapsin Phosphorylation in Augmentation and Potentiation of Spontaneous Glutamate Release
por: Cheng, Qing, et al.
Publicado: (2018)

Physiological Perspectives on Molecular Mechanisms and Regulation of Vesicular Glutamate Transport: Lessons From Calyx of Held Synapses
por: Hori, Tetsuya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_71ftejhp4rhik64mfbso20j6uo